These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23523785)

  • 1. Ceramide mediates lung fibrosis in cystic fibrosis.
    Ziobro R; Henry B; Edwards MJ; Lentsch AB; Gulbins E
    Biochem Biophys Res Commun; 2013 May; 434(4):705-9. PubMed ID: 23523785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
    Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
    Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the inflammasome by ceramide in cystic fibrosis lungs.
    Grassmé H; Carpinteiro A; Edwards MJ; Gulbins E; Becker KA
    Cell Physiol Biochem; 2014; 34(1):45-55. PubMed ID: 24977480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
    Becker KA; Grassmé H; Zhang Y; Gulbins E
    Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
    Becker KA; Tümmler B; Gulbins E; Grassmé H
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory role of extracellular sphingolipids in Cystic Fibrosis.
    Zulueta A; Peli V; Dei Cas M; Colombo M; Paroni R; Falleni M; Baisi A; Bollati V; Chiaramonte R; Del Favero E; Ghidoni R; Caretti A
    Int J Biochem Cell Biol; 2019 Nov; 116():105622. PubMed ID: 31563560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.
    Brunkhorst R; Friedlaender F; Ferreirós N; Schwalm S; Koch A; Grammatikos G; Toennes S; Foerch C; Pfeilschifter J; Pfeilschifter W
    Neural Plast; 2015; 2015():503079. PubMed ID: 26605090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.
    Bodas M; Min T; Mazur S; Vij N
    J Immunol; 2011 Jan; 186(1):602-13. PubMed ID: 21135173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis.
    Peng H; Li C; Kadow S; Henry BD; Steinmann J; Becker KA; Riehle A; Beckmann N; Wilker B; Li PL; Pritts T; Edwards MJ; Zhang Y; Gulbins E; Grassmé H
    J Mol Med (Berl); 2015 Jun; 93(6):675-89. PubMed ID: 25616357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis.
    Yu H; Zeidan YH; Wu BX; Jenkins RW; Flotte TR; Hannun YA; Virella-Lowell I
    Am J Respir Cell Mol Biol; 2009 Sep; 41(3):367-75. PubMed ID: 19168701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection.
    Zhang Y; Li X; Grassmé H; Döring G; Gulbins E
    J Immunol; 2010 May; 184(9):5104-11. PubMed ID: 20351190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis.
    Siegmann N; Worbs D; Effinger F; Bormann T; Gebhardt M; Ulrich M; Wermeling F; Müller-Hermelink E; Biedermann T; Tighe M; Edwards MJ; Caldwell C; Leadbetter E; Karlsson MC; Becker KA; Gulbins E; Döring G
    Cell Physiol Biochem; 2014; 34(1):56-70. PubMed ID: 24977481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis.
    Walter S; Gulbins E; Halmer R; Jahromi NH; Becker KA; Schottek A; Blatti C; Davies L; Schnoeder L; Bertsch T; Engelhardt B; Fassbender K
    Neurosignals; 2019; 27(S1):20-31. PubMed ID: 31778303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD95 in pulmonary inflammation and infection in cystic fibrosis.
    Becker KA; Henry B; Ziobro R; Tümmler B; Gulbins E; Grassmé H
    J Mol Med (Berl); 2012 Sep; 90(9):1011-23. PubMed ID: 22314624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides.
    Ma J; Gulbins E; Edwards MJ; Caldwell CC; Fraunholz M; Becker KA
    Cell Physiol Biochem; 2017; 43(6):2170-2184. PubMed ID: 29069651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice.
    Dhami R; He X; Schuchman EH
    Cell Physiol Biochem; 2010; 26(4-5):749-60. PubMed ID: 21063112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets.
    McVey MJ; Kim M; Tabuchi A; Srbely V; Japtok L; Arenz C; Rotstein O; Kleuser B; Semple JW; Kuebler WM
    Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L625-L637. PubMed ID: 28283474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide in cystic fibrosis.
    Grassmé H; Riethmüller J; Gulbins E
    Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside.
    Garić D; De Sanctis JB; Wojewodka G; Houle D; Cupri S; Abu-Arish A; Hanrahan JW; Hajduch M; Matouk E; Radzioch D
    J Mol Med (Berl); 2017 Oct; 95(10):1053-1064. PubMed ID: 28695226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.